Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ethical considerations in testing workers for the -Glu69 marker of genetic susceptibility to chronic beryllium disease.

Journal of occupational and environmental medicine - 1 Apr 2006

Silver Ken, Sharp Richard R

Abstract excerpt

OBJECTIVE: The most compelling real-world example of genetic testing for susceptibility to a workplace exposure involves those industries that process or fabricate beryllium. We examined ethical issues associated with testing for susceptibility to chronic beryllium disease. METHODS: Using ethical and clinical criteria, we examined voluntary employer-sponsored testing programs in which individual results are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Confidentiality
Share to Genetic Markers
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to HLA-DP Antigens

Share to HLA-DP beta-Chains

Share to Predictive Value of Tests

Share to Risk Assessment

Source

Identifiers

PMID: 16607200
DOI: 10.1097/01.jom.0000200878.16077.3b

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ethical considerations in testing workers for the -Glu69 marker of genetic susceptibility to chronic beryllium disease.PMID 16607200Read ↗

Racial differences in prevalence of a supratypic HLA-genetic marker immaterial to pre-employment testing for susceptibility to chronic beryllium disease.Semantic proximity Read ↗

Genetic testing: ethical implications in the workplace.Semantic proximity Read ↗

HLA-DPB1 E69 genotype and exposure in beryllium sensitisation and disease.Semantic proximity Read ↗

Research to Practice Implications of High-Risk Genotypes for Beryllium Sensitization and Disease.Semantic proximity Read ↗

Some implications of genetic biomarkers in occupational epidemiology and practice.Semantic proximity Read ↗

Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers.Semantic proximity Read ↗

Risk estimation and value-of-information analysis for three proposed genetic screening programs for chronic beryllium disease prevention.Semantic proximity Read ↗

Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles.Semantic proximity Read ↗

HLA-DPB1 and chronic beryllium disease: a HuGE review.Semantic proximity Read ↗

Genetic susceptibility to occupational exposures.Semantic proximity Read ↗

Genetic susceptibility to beryllium: a case-referent study of men and women of working age with sarcoidosis or other chronic lung disease.Semantic proximity Read ↗

Genetic susceptibility testing for beryllium: worker knowledge, beliefs, and attitudes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.